Insulin Glargine (Lantus)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Insulin Glargine (Lantus), covering 2009-06-04 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes [Phase 3]